首页/数据集/Clinical and demographic characteristics of infants who received palivizumab versus control infants.

Clinical and demographic characteristics of infants who received palivizumab versus control infants.

Figshare2017-04-25 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Clinical_and_demographic_characteristics_of_infants_who_received_palivizumab_versus_control_infants_/4904453 数据链接链接失效反馈

官方服务：

资源简介：

Clinical and demographic characteristics of infants who received palivizumab versus control infants.

应用场景：

创建时间：

2017-04-25

医疗成本效益

呼吸道合胞病毒综合管理

To assess the cost-utility of palivizumab versus no prophylaxis in preventing severe respiratory syncytial virus (RSV) infection in Canadian moderate-to-late preterm (32–35 weeks’ gestational a

DataCite Commons2024-03-21 更新70

Guidances for the Respiratory Syncytial Virus Prophylactic Monoclonal Antibodies in Primary Care

呼吸道合胞病毒综合管理

初级卫生保健

Respiratory syncytial virus (RSV) is the primary viral pathogen responsible for acute lower respiratory tract infections in infants and young children, severely endangering children's health. In recen

科学数据银行2025-11-11 更新40

Retrospective Parameter Estimation and Forecast of Respiratory Syncytial Virus in the United States

传染病动力学模型

呼吸道合胞病毒综合管理

Recent studies have shown that systems combining mathematical modeling and Bayesian inference methods can be used to generate real-time forecasts of future infectious disease incidence. Here we develo

Figshare2016-10-12 更新10

The effectiveness of palivizumab prophylaxis for RSV infections in subgroups.

药物效果评估

呼吸道合胞病毒综合管理

aPresence (+) or absence (–) of chronic lung disease (CLD).bNumber (No.) of hospitalization due to respiratory syncytial virus infection.Abbreviations: RSV, respiratory syncytial virus; OR, odds ratio

Figshare2015-12-02 更新40

DataSheet_4_Cilia-related gene signature in the nasal mucosa correlates with disease severity and outcomes in critical respiratory syncytial virus bronchiolitis.xlsx

呼吸道合胞病毒综合管理

纤毛细胞生物学

BackgroundRespiratory syncytial virus (RSV) can cause life-threatening respiratory failure in infants. We sought to characterize the local host response to RSV infection in the nasal mucosa of infants

NIAID Data Ecosystem20

Clinical and demographic characteristics of infants who received palivizumab versus control infants.

资源简介：

相关数据集